Viewing Study NCT02248168


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2025-12-26 @ 6:58 AM
Study NCT ID: NCT02248168
Status: COMPLETED
Last Update Posted: 2014-09-25
First Post: 2014-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module